The short answer
You need to verify two different things:
- Spectrum: Is the panel actually emitting the advertised wavelength bands, and are they reaching the treatment area?
- Dose: Is each band delivering enough optical power per unit area for the specific protocol you are evaluating?
A bright-looking panel, a list of LED colors, or a phone-camera image answers neither question reliably. The strongest check combines a calibrated spectrometer (for wavelength and spectral output) with a calibrated optical power meter or radiometer (for irradiance at the skin). Then document the exposure conditions and calculate fluence—the energy per area—from the measured irradiance and time.
There is no universal number that makes every wavelength “therapeutic.” Photobiomodulation research varies by wavelength, tissue, irradiance, fluence, pulse pattern, treatment area, and distance. A review in Photomedicine and Laser Surgery notes that these parameters must be considered together and that clinical protocols are not universally agreed upon (review of light parameters and photobiomodulation efficacy).
What each measurement can prove
Wavelength: use a spectrometer, not your eyes
A spectrometer separates light by wavelength. A spectroradiometer adds calibrated radiometric information, allowing the result to be expressed as spectral irradiance rather than uncalibrated detector counts. That distinction matters: an instrument may show a peak at a plausible wavelength while still giving an inaccurate power value if its response has not been calibrated across the relevant range.
Ask for, or measure, a spectrum at the same distance and geometry as use. Look for:
- the peak wavelength of each channel;
- the width of each peak or band;
- unwanted emissions or substantial spectral overlap; and
- whether the peaks remain present when all channels run together, rather than only in a single-color test.
A spectrum showing a peak confirms emission in that band. It does not by itself prove that the band has useful irradiance at the skin.
Irradiance: measure power per area at the target
Irradiance is usually reported in W/cm² or mW/cm². It is the rate at which optical power arrives over an area. To assess individual channels, the meter must have a known, appropriate spectral response—or the measurement must be corrected using spectral data.
A broadband “light meter” or solar meter may respond poorly to narrow LED bands or near-infrared light. A lux meter is designed around human visual sensitivity, so it is not a substitute for a radiometric measurement of red or infrared output.
Measure at the treatment plane, not merely at the panel face. Record distance, angle, sensor area, warm-up time, operating mode, and whether the reading is a point value or an average over the treatment area.
Fluence: calculate the delivered energy
For continuous output:
Fluence (J/cm²) = irradiance (mW/cm²) × exposure time (seconds) ÷ 1,000
For example, a measured 40 mW/cm² for 300 seconds corresponds to 12 J/cm² at that measurement point. If a channel is pulsed, use its time-averaged irradiance or account for the duty cycle; do not automatically multiply the peak reading by the session duration.
This calculation tells you what the device delivered under the measured conditions. It does not establish that the result is clinically appropriate. The relevant comparison is a validated protocol for the particular indication, tissue, wavelength, and device geometry—not a generic “therapeutic level.”
A practical verification workflow
1. Define the claim before measuring
Write down every advertised wavelength or band, the intended treatment distance, session duration, operating modes, and the body area to be covered. Decide whether you need a screening check or evidence suitable for a clinical, purchasing, or regulatory decision.
Also ask whether the claim is for each channel separately or for all wavelengths combined. A panel can have a respectable total output while one channel contributes very little.
2. Test channels separately, then together
If the controls permit it, run each wavelength channel alone and record its spectrum and irradiance. Repeat with the channels together. If channels cannot be isolated, use a spectroradiometer to resolve their spectral contributions and request channel-level test data from the manufacturer.
Do not assume that an “NIR” setting is one wavelength. It may be a band, several peaks, or a mixture that needs to be reported as such.
3. Match the measurement geometry to real use
Set the panel and detector as they would be positioned relative to the skin. Keep the sensor perpendicular to the panel unless the intended use is angled. Measure at the stated distance, and repeat at the closest and farthest distances a user is likely to choose.
Map several points across the treatment area: center, corners, edges, and any obvious gaps between modules. Report the mean and range, not just the highest hotspot. If the sensor is smaller than the illuminated area, take enough readings to reveal non-uniformity.
4. Check time, heat, and pulsing
Let the panel reach its normal operating condition before recording. Note whether output changes as the unit warms. Use the actual timer setting and verify whether the timer represents on-time or includes pulsed cycles. Observe temperature separately: a power reading is not a temperature reading, and a device marketed as non-heating should not be assumed to be risk-free simply because the light feels comfortable.
5. Record uncertainty and repeatability
A useful report includes the instrument model, calibration date and range, detector orientation, distance, sensor aperture, room conditions, channel settings, readings, and calculation. Repeat measurements after repositioning the detector. If the claimed difference between two channels is smaller than the instrument’s uncertainty, the test cannot confidently distinguish them.
NIST’s description of spectral-irradiance calibration emphasizes traceability and an explicit assessment of random and systematic errors. For a serious comparison, look for calibration documentation and an uncertainty statement, not just the word “calibrated” (NIST spectral irradiance calibration information).
How to judge a manufacturer’s test report
A credible report should identify:
- the exact unit or production sample tested;
- each wavelength peak and, ideally, its bandwidth;
- irradiance for each band or channel—not only combined power;
- measurement distance, angle, active area, and operating mode;
- whether values are peak, average, or spatially averaged;
- instrument type, spectral range, calibration, and uncertainty; and
- whether output was measured continuously or with pulse timing accounted for.
Be cautious when a report gives only LED count, electrical wattage, total optical power, or a single center-point irradiance. Electrical input is not optical output, and total optical output cannot show whether one wavelength is underpowered. A wavelength printed on a specification sheet is an intended component value, not independent proof of delivered dose.
If the report does not describe these conditions, ask the manufacturer to clarify them. If the answer remains vague, an independent optical laboratory is the appropriate next step—especially when the result will guide treatment of a medical condition or a substantial purchase.
Common shortcuts that fail
- “It looks equally bright.” Human vision is not equally sensitive to all wavelengths, and near-infrared light may be invisible.
- “My phone camera sees every color.” Cameras apply automatic exposure, filtering, and color processing; they are not calibrated radiometers and may not detect infrared reliably.
- “There are many LEDs, so every band must be strong.” LED count does not reveal optical efficiency, drive current, beam angle, or channel balance.
- “The total mW/cm² is therapeutic.” A total conceals the contribution of each band and says nothing about whether the chosen protocol fits the indication.
- “One meter reading settles it.” A detector’s spectral response, position, beam non-uniformity, pulsing, and calibration all affect the result.
Safety and decision thresholds
Do not dismantle the panel, bypass controls, stare into bright emitters, or use improvised electrical tests. Follow the device’s eye, photosensitivity, medication, heat, and timing warnings. FDA draft guidance for photobiomodulation devices describes them as intended to deliver a non-heating dose for clinical benefit and includes home-use, labeling, and electrical-safety considerations; it is guidance, not a universal endorsement of every consumer panel (FDA PBM device guidance).
For personal curiosity, a repeatable spectral check plus distance-specific irradiance measurements can reveal whether the advertised channels are plausible. For a medical decision, ask a clinician and use a protocol with evidence for the condition. For a purchase or product dispute, require channel-level, geometry-specific data from a calibrated test—or have the unit tested independently.
The most defensible conclusion is not “this panel is therapeutic” based on one number. It is: “At this distance and setting, the panel emitted these measured spectral bands, delivered this irradiance at these locations, and produced this calculated fluence over this time, within the stated uncertainty.”
